Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.
2.

[Adjuvant radiotherapy after radical prostatectomy. Apropos of a series of 73 patients in Lyons (France)].

Fric D, Ayzac L, Coquard R, Dubernard P, Maréchal JM, Leriche A, Gérard JP.

Cancer Radiother. 1997;1(1):52-9. Review. French.

PMID:
9265534
3.

The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.

Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U.

J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.

PMID:
18550106
4.

Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Murphy GP, Busch C, Abrahamsson PA, Epstein JI, McNeal JE, Miller GJ, Mostofi FK, Nagle RB, Nordling S, Parkinson C, et al.

Scand J Urol Nephrol Suppl. 1994;162:7-42; discussion 115-27. Review.

PMID:
7817162
5.

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.

Epstein JI.

J Urol. 2011 Sep;186(3):790-7. doi: 10.1016/j.juro.2011.02.2695. Epub 2011 Jul 23. Review.

PMID:
21788055
6.

An update of the Gleason grading system.

Epstein JI.

J Urol. 2010 Feb;183(2):433-40. doi: 10.1016/j.juro.2009.10.046. Epub 2009 Dec 14. Review.

PMID:
20006878
7.

Contemporary grading for prostate cancer: implications for patient care.

Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin M, Epstein JI.

Eur Urol. 2013 May;63(5):892-901. doi: 10.1016/j.eururo.2012.10.015. Epub 2012 Oct 17. Review.

PMID:
23092544
8.
9.

The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.

Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD.

Cancer. 2007 Jan 1;109(1):13-24. Review.

10.

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

Epstein JI, Amin M, Boccon-Gibod L, Egevad L, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Srigley JR, Wheeler TM, Montironi R.

Scand J Urol Nephrol Suppl. 2005 May;(216):34-63. Review.

PMID:
16019758
11.

Gleason grading and prognostic factors in carcinoma of the prostate.

Humphrey PA.

Mod Pathol. 2004 Mar;17(3):292-306. Review.

12.

Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.

Cussenot O, Villette JM, Cochand-Priollet B, Berthon P.

Prostate Suppl. 1998;8:43-51. Review.

PMID:
9690663
13.

Grading prostate cancer.

Bostwick DG.

Am J Clin Pathol. 1994 Oct;102(4 Suppl 1):S38-56. Review.

PMID:
7524306
14.
15.

[Value of biopsies in staging of prostatic cancer before radical prostatectomy].

Salomon L, Hoznek A, Lefrere-Belda MA, Bellot J, Chopin D, Abbou CC.

Prog Urol. 1998 Dec;8(6):969-76. Review. French.

PMID:
9894255
16.

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la Taille A, Katz AE, Olsson CA, Ennis RD.

Urology. 1999 Mar;53(3):542-7. Review.

PMID:
10096381
17.

Radical prostatectomy for carcinoma of the prostate.

Ohori M, Kattan M, Scardino PT, Wheeler TM.

Mod Pathol. 2004 Mar;17(3):349-59. Review.

18.

[Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].

Segawa N, Inamoto T, Ibuki N, Mizutani Y, Azuma H, Tsuji M, Katsuoka Y.

Hinyokika Kiyo. 2010 Jan;56(1):49-54. Review. Japanese.

19.

[A case report of prostate cancer with Paneth cell-like change].

Soga N, Suzuki R, Komeda Y.

Hinyokika Kiyo. 1995 Nov;41(11):891-4. Review. Japanese.

20.

New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.

Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F.

Int J Clin Pract. 2006 Apr;60(4):462-70. Review.

PMID:
16620361

Supplemental Content

Support Center